Total Payments
$1,525
2024 Payments
$95.77
Companies
19
Transactions
73
Medicare Patients
3,895
Medicare Billing
$280,138
Payment Breakdown by Category
Food & Beverage$1,305 (85.6%)
Education$219.12 (14.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,305 | 68 | 85.6% |
| Education | $219.12 | 5 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $312.41 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $237.72 | 13 | $0 (2023) |
| Allergan, Inc. | $172.10 | 8 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $160.50 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $121.56 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $94.99 | 1 | $0 (2023) |
| Organogenesis Inc. | $85.18 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $66.00 | 6 | $0 (2022) |
| Esperion Therapeutics, Inc. | $55.19 | 4 | $0 (2024) |
| Lilly USA, LLC | $44.73 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.77 | 5 | AstraZeneca Pharmaceuticals LP ($61.24) |
| 2023 | $238.14 | 8 | AstraZeneca Pharmaceuticals LP ($128.29) |
| 2022 | $204.59 | 13 | AstraZeneca Pharmaceuticals LP ($75.56) |
| 2021 | $81.24 | 6 | Esperion Therapeutics, Inc. ($35.74) |
| 2020 | $38.40 | 3 | GlaxoSmithKline, LLC. ($13.14) |
| 2019 | $43.61 | 2 | Allergan Inc. ($29.99) |
| 2018 | $337.37 | 13 | Novartis Pharmaceuticals Corporation ($107.94) |
| 2017 | $485.45 | 23 | GlaxoSmithKline, LLC. ($147.29) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Respiratory | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Respiratory | ||||||
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Respiratory | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Respiratory | ||||||
| 04/24/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $48.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Respiratory | ||||||
| 11/29/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Respiratory | ||||||
| 10/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Respiratory | ||||||
| 07/22/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 07/19/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2022 | Almatica Pharma LLC | GRALISE (Drug), CITALOPRAM, SERTRALINE HCL | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 04/20/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes Care | ||||||
| 04/19/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 03/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 793 | 1,332 | $138,301 | $59,906 |
| 2022 | 15 | 1,037 | 1,753 | $185,326 | $78,123 |
| 2021 | 12 | 1,073 | 1,889 | $186,081 | $83,717 |
| 2020 | 12 | 992 | 1,665 | $163,790 | $58,392 |
Total Patients
3,895
Total Services
6,639
Medicare Billing
$280,138
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 368 | $60,720 | $27,687 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 137 | 137 | $24,075 | $16,066 | 66.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 161 | $21,735 | $8,073 | 37.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 184 | 356 | $13,528 | $4,372 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,375 | $2,050 | 27.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 57 | 149 | $4,470 | $679.61 | 15.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 76 | $3,648 | $663.51 | 18.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,875 | $195.70 | 10.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 35 | $875.00 | $119.35 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 400 | $66,000 | $32,126 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 141 | 141 | $24,795 | $16,905 | 68.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 218 | $29,430 | $11,875 | 40.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 239 | 490 | $18,620 | $5,989 | 32.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 23 | 23 | $9,775 | $2,907 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $9,735 | $2,370 | 24.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 12 | 12 | $9,000 | $1,544 | 17.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 16 | 33 | $1,980 | $969.75 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 72 | 92 | $4,416 | $857.21 | 19.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 65 | 172 | $5,160 | $836.58 | 16.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 18 | $1,230 | $695.09 | 56.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 16 | $1,600 | $614.88 | 38.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 33 | $2,475 | $287.13 | 11.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 39 | $975.00 | $133.48 | 13.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 33 | $135.48 | $13.38 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 254 | 473 | $78,045 | $38,282 | 49.1% |
About Dr. Bertin Chevis, M.D
Dr. Bertin Chevis, M.D is a Family Medicine healthcare provider based in Bay St Louis, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649228529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bertin Chevis, M.D has received a total of $1,525 in payments from pharmaceutical and medical device companies, with $95.77 received in 2024. These payments were reported across 73 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,305).
As a Medicare-enrolled provider, Chevis has provided services to 3,895 Medicare beneficiaries, totaling 6,639 services with total Medicare billing of $280,138. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bay St Louis, MS
- Active Since 05/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1649228529
Products in Payments
- BREZTRI (Drug) $154.42
- ENTRESTO (Drug) $121.56
- XARELTO (Drug) $120.25
- ANORO ELLIPTA (Drug) $117.47
- FARXIGA (Drug) $108.16
- TRELEGY ELLIPTA (Drug) $90.43
- Apligraf (Biological) $85.18
- VRAYLAR (Drug) $56.67
- NEXLETOL (Drug) $55.19
- LINZESS (Drug) $42.78
- VIIBRYD (Drug) $40.00
- Kerendia (Drug) $33.20
- BEVESPI AEROSPHERE (Drug) $31.48
- TRULICITY (Drug) $29.90
- Amitiza (Drug) $27.79
- SOLIQUA (Drug) $27.50
- TRINTELLIX (Drug) $25.65
- ANORO (Drug) $23.21
- NAMZARIC (Drug) $19.38
- FASENRA (Biological) $18.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bay St Louis
Christopher Jones, M.d, M.D
Family Medicine — Payments: $466.60
Family Medicine $466.60
Sahiba Ahluwalia, Md, MD
Family Medicine — Payments: $368.99
Family Medicine $368.99
Jessica Douglas, Md, MD
Family Medicine — Payments: $289.55
Family Medicine $289.55
Dr. Sidney Chevis, Md, MD
Family Medicine — Payments: $31.61
Family Medicine $31.61
Dr. William Kergosien, M.d, M.D
Family Medicine
Family Medicine
Tessa Helsel, Do, DO
Family Medicine
Family Medicine